Aktis Oncology(AKTS) - 2026 Q2 - Quarterly Results

Financial Results - Aktis Oncology, Inc. reported financial results for the year ended December 31, 2025, with a focus on operational performance and business updates[5]. - A press release detailing the financial results was issued on March 30, 2026, and is available as Exhibit 99.1[5]. - The financial statements and exhibits are not deemed "filed" under the Securities Exchange Act of 1934[6]. Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[4]. Report Signing - The report was signed by Kyle Kuvalanka, Chief Financial Officer, on March 30, 2026[12].